South African vaccine manufacturer Biovac has secured a further $20m (R327m) from two French development finance institutions. This brings its total fundraising to $128m (R2.4bn) and leaves the company within striking distance of its $180m (R2.95bn) target. Moreover, this new investment marks a significant milestone in the ongoing Biovac expansion fundraising effort. Agence Française de Développement and its private-sector arm,…
Tag: Sub-Saharan Africa
-
Zimbabwe National Health Strategy Aims to Transform Healthcare
Zimbabwe has taken a significant step towards reshaping its health system, launching a high-level validation workshop for its National Health Strategy 2026-2030. Health Minister Douglas Mombeshora told stakeholders the strategy arrives at a “defining moment” for the country. He urged them to view it not as a policy document, but as an actionable roadmap. Importantly, it is aligned with Zimbabwe’s…
-
Zambia-US Health Funding Deal Stalled Over Mineral Access
Zambia has publicly opposed a US attempt to link health funding to access to critical minerals, giving the clearest account yet of why two proposed bilateral agreements have stalled. The Zambia-US Health Funding Deal has become a key point of contention in discussions between the two countries. Foreign Minister Mulambo Haimbe issued a detailed statement rejecting the terms of both…
-
Aspen Targets Mounjaro Expansion in Africa Following Approval
Aspen targeting Mounjaro expansion will bring the high-demand drug Mounjaro to Sub-Saharan Africa. Mounjaro is also known as tirzepatide. Launches across the continent are anticipated in 2026. CEO Stephen Saad confirmed this plan. He announced it in his annual letter to shareholders. The move follows major success in South Africa. It also comes after a new regulatory approval. This approval…